-
Global branded generics market expected to double by 2026
VALLEY COTTAGE, N.Y. — The global branded generics market will more than double in value in just 10 years from a current $200 billion to $413.8 billion in 2016, according to a new report from Future Market Insights.
The size of the global branded generics market is estimated to grow at a 7.3% compound annual growth rate for the 2016-2026 time period, FMI added.
-
Amneal intros generic Lotronex tablets
BRIDGEWATER, N.J. — Amneal Pharmaceuticals on Monday launched its generic of Lotronex (alosetron hydrochloride) tablets. The drug is indicated to treat irritable bowel syndrome in some women whose main symptom is diarrhea, whose IBS has lasted six months or longer or who have not been helped by other treatments.